Updates and Announcements Learn more about the Updates and Announcements offered by Horizon NJHealth. Recall of Milk of Magnesia 2400 mg/30 mL Oral Suspension Recall of Humalog KwikPen U-100 Recall of Magnesium Hydroxide 1200 mg/Aluminum Hydroxide 1200 mg/Simethicone 120 mg per 30 mL Recall of Symjepi (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes Need Help With Your Utility Bills? Recall of Senna Syrup 8.8mg/5mL At-Home COVID-19 Testing Recall of Enoxaparin Sodium Injection, 40mg/0.4mL Recall of Lidocaine HCl Topical Solution 4% Recall of Glucagon Emergency Kit for Low Blood Sugar Recall of Firvanq Oral Solution 50mg/mL Kit Recall of Chantix Tablets Recall of Lidocaine HCl Topical Solution 4% Recall of Atovaquone Oral Suspension 750mg/5mL New Behavioral Health Benefit: Care Management Services Interoperability Support New benefit for members: Doula services LogistiCare is now Modivcare COVID-19 vaccines available in Essex County Preventive Health: Medicaid Update Recall of NP Thyroid Tablets NJ Residents can get opioid-overdose antidote naloxone at no cost from September 24 to 26 Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Recall of Daptomycin for Injection, 500 mg/vial DIR Services for children diagnosed with Autism Spectrum Disorder New benefit: Peer Recovery Support Services Taking care of your mental health during and after pregnancy What You Need to Know About COVID-19 Changes to Management of the Horizon Behavioral Health Program Recall of Metformin Hydrochloride Extended Release Tablets, 500mg and 750mg Recall of NP Thyroid Tablets Recall of Metformin Hydrochloride Extended Release Tablets, 500mg A message from the State of New Jersey Department of Human Services: How NJ FamilyCare is working to support New Jerseyans’ health care needs during the Coronavirus emergency Coronavirus resources Referrals no longer needed! Services for children diagnosed with Autism Spectrum Disorder 3 ways to get care Removal of Ranitidine from the market Teledentistry is now available Attention: Manufacturer recall of Phenytoin Suspension Language translator services Attention Members: Manufacturer recall of Lamotrigine 100 mg tablets Atención a los miembros: Retiro del fabricante de comprimidos, cápsulas y jarabes de ranitidine Attention Members: Manufacturer recall of Ranitidine Tablets, Capsules and Syrup ¿Busca maneras de retribuir en esta época de fiestas? Looking for ways to give back this holiday season? Atención miembros: Retiro del fabricante de comprimidos y cápsulas de ranitidina Attention Members: Manufacturer recall of Ranitidine Tablets & Capsules Important Information for SNAP Recipients about your February Benefits A message from Human Services Commissioner Johnson: Fighting Lead with Nutrition Attention Members: Manufacturer recall of Natpara for Injection Recall of Losartan Potassium and Losartan Potassium and Hydrochlorothiazide tablets Attention Members: Manufacturer recall of Fluorouracil Injection Recall of Promacta 12.5mg for Oral Suspension Updates to the Internal Appeal process Recall of 8.4% Sodium Bicarbonate Injection Organ and tissue donation saves lives Recall of Fentanyl Transdermal 12 mcg/h Patches Recall of Ceftriaxone for Injection Recall of Losartan Potassium Hydrochlorothiazide Tablets Recall of Losartan Potassium Tablets Recall of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan Tablets USP Recall of Valsartan, Amlodipine/Valsartan and Valsartan/Hydrochlorothiazide Tablets Treatment for substance use disorders at Long-Term Residential facilities Retiro de jeringas precargadas de dosis única de Symjepi (epinefrina) inyectable de 0.15 mg (0.15 mg/0.3 ml) y 0.3 mg (0.3 mg/0.3 ml)